Page S Gilmour

Title: Page S Gilmour: Innovator in Monoclonal Antibody Research

Introduction

Page S Gilmour is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, Gilmour's work has the potential to impact therapeutic approaches for various viral infections.

Latest Patents

Gilmour's latest patents focus on neutralizing monoclonal antibodies to the respiratory syncytial virus (RSV). The inventions relate to the identification and cloning of a novel neutralizing human monoclonal antibody to RSV. These patents provide antibodies, fragments of antibodies retaining RSV-binding ability, and chimeric antibodies that maintain this binding ability. Additionally, the inventions include pharmaceutical compositions containing these antibodies, isolated nucleic acids encoding the antibodies, and host cells transformed with these nucleic acids. The patents also outline diagnostic and therapeutic methods that utilize the antibodies and nucleic acids developed through her research.

Career Highlights

Gilmour is associated with Intracel Resources LLC, where she continues to advance her research in monoclonal antibodies. Her work is characterized by a commitment to innovation and the application of scientific knowledge to real-world health challenges.

Collaborations

Some of her notable coworkers include Glenn R Pilkington and Robert M Chanock. Their collaborative efforts contribute to the ongoing research and development in the field of monoclonal antibodies.

Conclusion

Page S Gilmour's contributions to the field of monoclonal antibody research exemplify the impact of innovative thinking in biomedical science. Her patents and ongoing work hold promise for advancing therapeutic options for viral infections.